Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

Technologies to Enhance Cell Line Productivity and Expand Antibody-Drug Conjugate Therapeutic Window to be Presented by Catalent Biologics at PEGS


Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, today announced that two Catalent Biologics experts will present at the upcoming 16th Annual PEGS Boston Virtual Conference & Expo, taking place between Aug. 31 – September 4, 2020.

On Wednesday, Sept. 2 at 9:45 a.m. EDT, Gregory Bleck, Ph.D., Global Head of R&D, Catalent Biologics, will present “GPEx® Boost – A Novel Approach for High-Expressing CHO Cell Line Engineering” during the “Optimizing Protein Expression” stream. Dr. Bleck will explain how the next generation of Catalent’s GPEx cell line development technology can result in highly specific productivities, titers, and improved cell growth characteristics for most protein products.

Also on Wednesday, at 3:05 p.m. EDT, during the “Engineering Antibody-Drug Conjugates” stream, Robyn Barfield, Ph.D., Group Leader, Catalent Biologics, will discuss Catalent’s proprietary SMARTag® technology, which uses a simple, robust manufacturing process to generate stable, site-specific antibody-drug conjugates (ADCs). In her presentation, titled “Novel SMARTag Linkers Enable Better-Tolerated ADCs,” Dr. Barfield will discuss how the technology can offer wider therapeutic windows, illustrated through a comparison between Catalent’s anti-HER2 RED-106 ADC, and the related drug, T-DM1.

During the virtual event, Dr. Barfield will also present the case study in her presentation as a poster, “A Novel HER2-Targeted Antibody-Drug Conjugate Offers the Possibility of Clinical Dosing at Trastuzumab-Equivalent Exposure Levels.”

Dr. Bleck has more than 20 years of experience in biopharmaceutical research and development. He has a bachelor’s degree and doctorate from the University of Wisconsin-Madison and performed postdoctoral work at the University of Illinois-Urbana-Champaign, working in the areas of gene regulation and expression. At Catalent, Dr. Bleck has transferred his knowledge of gene expression and transgenic systems to the development and continued optimization of retrovector expression systems and development of the proprietary GPEx process.

Dr. Barfield has more than 10 years’ experience working in bioconjugation, and joined Catalent Biologics when it acquired Redwood Bioscience in 2014. She has a doctorate in cell and molecular biology from the University of Pennsylvania School of Medicine and a bachelor’s degree in genetics and cell biology, from the University of Georgia.

The event’s presentations and panel discussions will be available to view on-demand through the conference platform. For more information about the event, please visit biologics.catalent.com/events/pegs-boston/

Catalent, GPEx and SMARTag are registered trademarks of Catalent, Inc. or its affiliates or subsidiaries.

About Catalent Biologics

Catalent Biologics is a global leader in development, manufacturing and analytical services for new biological entities, cell and gene therapies, biosimilars, sterile injectables, and antibody-drug conjugates. With over 20 years of proven expertise, Catalent Biologics has worked with 600+ mAbs and 80+ proteins, produced 13 biopharmaceutical drugs using GPEx® cell line development technology, and manufactured 35+ commercially approved products. Catalent Cell & Gene Therapy, a unit of Catalent Biologics, is a full-service partner for adeno-associated virus (AAV) vectors and CAR-T immunotherapies, with deep experience in viral vector scale-up and production. Catalent recently acquired MaSTherCell, adding expertise in autologous and allogeneic cell therapy development and manufacturing. Catalent Cell & Gene Therapy has produced 100+ cGMP batches across 70+ clinical and commercial programs. For more information, visit biologics.catalent.com

About Catalent

Catalent is the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products. With over 85 years serving the industry, Catalent has proven expertise in bringing more customer products to market faster, enhancing product performance and ensuring reliable global clinical and commercial product supply. Catalent employs over 13,500 people, including over 2,400 scientists and technicians, at more than 40 facilities, and in fiscal year 2019 generated over $2.5 billion in annual revenue. Catalent is headquartered in Somerset, New Jersey. For more information, visit http://www.catalent.com

More products. Better treatments. Reliably supplied.™

Share article on social media or email:

Victor Foods announces increased production capacity of their clean label hummus products to accommodate more grocery chains in the western USA


Victor Foods Logo

VICTOR FOODS is a Spokane-based company specializing in clean label hummus products. Winner of the best locally produced foods (not only hummus) in the Inland NorthWest consecutively for the past 8 years. While VICTOR FOODS products are not “officially certified” organic, organic chickpeas are the main ingredient. Being a clean label product, VICTOR FOODS hummus has:

NO preservatives,

NO blended or filler oils (canola, soy),

NO dairy,

NO gluten,

NO GMO.

The authentic and delectable hummus flavors of VICTOR FOODS are, also, very low in lectins (anti-nutrients) due to a unique proprietary cooking process. To keep all the natural nutrients from degrading, VICTOR FOODS does not pasteurize their products.

“We take great care to ensure that we have the most clean label of any hummus brand,” Victor Azar, founder of VICTOR FOODS, declared passionately. “We replicate a home-made, hand-crafted product by soaking and cooking the beans correctly with a proprietary process.”

By not including filler oils, Victor’s hummus products have as little as half the calories of many other brands.”

For the past ten years, VICTOR FOODS has been serving independent stores and regional grocery chains throughout the Pacific NorthWest, USA. At this time, there is more capacity to accommodate additional grocery chains who appreciate offering a healthy, clean and tempting product to their evermore critical and demanding shoppers.

Article URL: https://www.yahoo.com/lifestyle/popular-hummus-chickpea-brands-contain-153700047.html

Victor Foods Ad: https://youtu.be/pVExAX_TGwE

Victor Foods URL: https://www.victorfoods.com

Share article on social media or email:

The Radiosurgery Society Announces ‘For Residents, By Residents’ Webinar Series for Residents Interested in Stereotactic Radiosurgery/Stereotactic Body Radiation Therapy


News Image

This is a fantastic opportunity for residents and junior faculty who are interested in SRS/SBRT to connect with each other and with more seasoned physicians in this space, and to learn skills that will be invaluable in developing their careers.

The Radiosurgery Society (RSS), a non-profit medical society dedicated to advancing the science and clinical practice of radiosurgery, today announced that its launching a ‘For Residents, By Residents’ Webinar Series designed to foster the development of leaders in stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) amongst radiation oncology, physics, and neurosurgery residents.

The RSS ‘For Residents, By Residents’ Webinar Series consists of five monthly webinars beginning in October 2020 and ending in February 2021. The entire series is being planned, executed, and moderated by residents to best address the unique needs and interests of residents pursuing a career in the fields of radiation oncology, physics and neurosurgery. Featured topics include:


  • What Defines a Productive Mentor/Mentee Relationship & Survey Highlights: October 14, 2020 at 9:00 am PT/12:00 pm ET
  • Integrating SRS/SBRT into a New Practice: November 11, 2020 at 9:00 am PT/12:00 pm ET
  • Building a 5-year Research/Practice Plan/Academic Career Building: December 16, 2020 at 9:00 am PT/12:00 pm ET
  • How to Market Yourself for a Career in SRS/SBRT: January 13, 2021 at 2:00 pm PT/5:00 pm ET
  • Navigating Tumor Board Discussions as a Radiosurgeo: February 11, 2021 at 9:00 am PT/12:00 pm ET


Co-Chairs of RSS Residents Committee are Aviva Berkowitz, M.D. from Montefiore Medical Center and Evan Thomas, M.D., Ph.D., from University of Alabama, Birmingham. The Advising Professor for Neurosurgery is Susan Pannullo, M.D. from New York-Presbyterian Hospital/Weill Cornell Medical Center; the Advising Professor for Radiation Oncology is Nina Mayr, M.D., from the University of Washington; and the Advising Professor for Medical Physics is Indrin Chetty, Ph.D., from Henry Ford Cancer Institute.

“The RSS Residents Committee is a group of collegial experts focused on the goal of enhancing mentorship and educational experiences of those training in the field of radiosurgery,” said Indrin Chetty, Ph.D., Director of the Radiation Physics Division in the Department of Radiation Oncology at Henry Ford Cancer Institute. “The committee members are actively engaged in a variety of activities, such as webinars, didactic and ‘hands-on’ training, and novel research opportunities facilitated by the RSSearch Patient Registry.”

In addition to the ‘For Residents, By Residents’ Webinar Series, the RSS is pleased to announce its Mentorship and Career Pathways Program, designed to provide mentorship and coaching opportunities to residents pursuing careers as surgeons, radiation oncologists and physicists focused on the practice of radiosurgery. Mentors help these residents navigate the challenges as changes they may face as they evolve in their professional careers.

“The RSS Resident Committee is extremely excited to launch our very first resident driven webinar series highlighting our new Mentorship and Career Pathways Program,” said Aviva Berkowitz, M.D., Chief Resident Physician, PGY-5 Radiation Oncology, Montefiore Medical Center. “This is a fantastic opportunity for residents and junior faculty who are interested in SRS/SBRT to connect with each other and with more seasoned physicians in this space, and to learn skills that will be invaluable in developing their careers.”

The Radiosurgery Society invites those who are interested in participating in the RSS Mentorship and Career Pathways Program to complete an application to be matched with a mentor or mentee. Eligible mentees are residents or trainees in the fields of radiation oncology, physics, and neurosurgery. Eligible mentors include all attending physicians and seasoned physicists in those fields. The RSS Mentorship and Career Pathways program is open to both members and non-members of the Radiosurgery Society.

Those interested in receiving an application to become a mentor or mentee as part of the RSS Mentorship and Career Pathways Program should contact mentorship@therss.org.

About the Radiosurgery Society®

The Radiosurgery Society (RSS) – a non-profit, independent, multi-disciplinary organization of surgeons, radiation oncologists, physicists, and allied professionals, who are dedicated to advancing the science and clinical practice of radiosurgery. Originally formed in 2002 and becoming (501c6) in 2008, the Radiosurgery Society today (http://www.therss.org) represents approximately 600 members who perform stereotactic body radiotherapy and radiosurgery in hospitals and freestanding centers throughout the world.

Share article on social media or email:

A Comparison of FDA, EMA & PMDA Regulatory Guidance for In Vitro Drug-Drug Interaction (DDI) Assessments, Upcoming Webinar Hosted by Xtalks


Xtalks Life Science Webinars

Drug-drug interaction status for a molecule can be of great importance – for example, a high drug-drug interaction status as a victim drug (high fraction metabolized, small therapeutic window) is at risk of restrictive labeling and even non-approval.

Join David Wilkinson, Principal Study Director, Metabolism, Covance in a live webinar on Thursday, September 10, 2020 at 10am EDT (3pm BST/UK).

Assessment of drug-drug interactions is an increasingly important component of drug development to help ensure safe efficacious medicines. Since 1997, the regulatory agencies FDA, EMA and PMDA have endorsed the use of in vitro metabolism studies to assess the DDI potential of new chemical entities (NCE). Over the past 10 years, however, scientific progress has been rapid, fueled by sophisticated in vitro models and in silico predictive programs.

To reflect this scientific progress, the FDA, EMA and Japan’s MHLW (PMDA) have issued updated guidance/guidelines outlining what in vitro data should be obtained, mainly focused on CYP enzymes and drug transporters, and how this should be processed with possible consequences for potential clinical assessment and product labeling. This webinar will review and compare these three regional guidelines for testing new chemical entities for their potential drug-drug interactions.

Drug-drug interaction status for a molecule can be of great importance – for example, a high drug-drug interaction status as a victim drug (high fraction metabolized, small therapeutic window) is at risk of restrictive labeling and even non-approval.

For more information or to register for this event, visit A Comparison of FDA, EMA & PMDA Regulatory Guidance for In Vitro Drug-Drug Interaction (DDI) Assessments.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

Pace Analytical® Acquires Emerson Resources, Inc. Adding Clinical Trial Material Production Capabilities


Clinical trials

Pace Life Sciences Lab Services

Adding Emerson Resources to our portfolio allows Pace Life Sciences to further support our pharmaceutical and biopharmaceutical clients from early-stage research and development through phase 2 clinical trial material manufacturing.

Pace Analytical® Services, LLC, the largest American-owned laboratory network providing environmental and life sciences analytical information and services, today announced that it has acquired Emerson Resources, Inc., a pharmaceutical contract development and manufacturing organization (CDMO) specializing in dosage form development and clinical trial material manufacturing.

“Adding Emerson Resources to our portfolio allows Pace Life Sciences to further support our pharmaceutical and biopharmaceutical clients from early-stage research and development through phase 2 clinical trial material manufacturing”, comments Eric Roman, CEO of Pace Analytical®. “For clients, this means seamless support through each critical milestone in bringing a new drug to market”.

Services provided by Emerson Resources are focused on solid oral dosage formulation development and the production of clinical trial materials in support of bringing pharmaceutical and biopharmaceutical products to market. “This acquisition expands the capabilities of Pace Life Sciences to include clinical trial material manufacturing, greatly rounding out our overall service offerings”, adds Greg Kupp, COO of the Pace Analytical® Life Sciences Division. “The production of clinical trial materials requires a robust quality system, deep technical expertise, and the agility to ensure materials are ready for the clinic on time. Emerson is exceptional in these areas and represents a strong addition to the Pace Analytical lab network.”

Emerson Resources principals Jay Signorino, COO and Chip Signorino, CFO, are exiting the family business and have been looking for a buyer with a good cultural fit. “Pace holds the same cultural values and aspirations as Emerson”, notes Jay Signorino. “We believe this will be an easy and beneficial transition for the Emerson team and our customers”.

Over the next six months, Emerson Resources will transition to operating under the Pace Analytical® brand. The Emerson Resources lab is in the Philadelphia, PA area and joins Pace Life Sciences lab locations near Boston, MA, St. Paul, MN, and San Germán, PR. Kupp will oversee the management and operations of all Pace Life Sciences lab locations.

About Emerson Resources

For more than 12 years, Emerson Resources, a premier pharmaceutical development company, has delivered value-added service, ingredients, and expertise to clients in the pharmaceutical and biotech industries. Emerson Resources is a leader in dosage form development, manufacturing cGMP clinical supplies, analytical method development, analytical method validation, release testing, and stability testing. Based in Norristown, Pennsylvania, the Company’s expansive facility features development and analytical laboratories, a cGMP clinical supplies manufacturing plant, and a specialty ingredients excipients manufacturing center. For more information, visit emersonresources.com.

About Pace Analytical®

Pace Analytical® Services, LLC makes the world a safer, healthier place. For decades, we have been the trusted source for quality environmental and life sciences lab testing and analysis and the resource for scientific lab staffing, regulatory, and equipment services. Our work is done in partnership with our clients by providing the science and the data they need to make critical decisions that benefit us all. Pace delivers science better to businesses, industries, consulting firms, government agencies, and more through the largest, American-owned and nationally certified laboratory network. Science matters at PACELABS.com

Share article on social media or email:

The PAINWeek 2020 Live Virtual Conference (September 11-13) Welcomes ASPN, the American Society of Pain and Neuroscience


News Image

Having an ASPN track at PAINWeek is a natural evolution as both groups are heavily interested in alleviating chronic pain complaints through use of methods that are nonpharmacological

PAINWeek welcomes, for the first time, the American Society of Pain and Neuroscience (ASPN), which will present courses on Sunday, September 13. ASPN member Peter Pryzbylkowski, MD, commented, “Having an ASPN track at PAINWeek is a natural evolution as both groups are heavily interested in alleviating chronic pain complaints through use of methods that are nonpharmacological in nature.” Dr. Pryzbylkowski will present Fundamentals of Neuromodulation.

Presenter Sean Li, MD, stated, “ASPN is a unique and new professional society developed to harness the talents of a diverse group of interventional pain physicians through the pursuit of clinical excellence, education, research, and innovation. The collaboration of PAINWeek and ASPN will further advance pain medicine by embracing interventional treatment options to alleviate chronic pain and suffering.” Dr. Li’s course is Peripheral Nerve Stimulations: Indications and Evidence. The ASPN track includes: Patient Identification Strategies for Neuromodulators and The Role of Combining Spinal Cord Stimulation & Intrathecal Therapy.

“We’re very pleased to welcome ASPN,” commented Mike Shaffer, Director of Business Development at PAINWeek. “We understand that the PAINWeek audience continues to have a heightened interest in interventional treatments for chronic pain, particularly neuromodulation. Therefore, ASPN’s unparalleled faculty and burgeoning reputation in our landscape make for a great fit. We’re looking forward to their track, and building on our partnership in the future.”

PAINWeek will also welcome the American Headache Society, International Pelvic Pain Society, American Society of Interventional Pain Physicians, and Osteoarthritis Research Society International.

To learn more about PAINWeek or to register, click here or visit https://www.painweek.org/conferences/painweek/live-virtual-conference.

About Global Education Group:

Global Education Group focuses on producing partnership-based CME for healthcare practitioners. The Global team works with a select group of medical education companies, associations, academic institutions and healthcare facilities to develop and accredit live healthcare conferences and workshops as well as online activities. With each partnership or joint providership, Global brings accreditation expertise, project management excellence and grant funding intelligence. Based in Littleton, Colo., Global has accreditation with commendation from the ACCME. Global also holds accreditations to offer continuing education for nurses, nurse practitioners, pharmacists, dietitians, dentists and psychologists. Global is a division of Ultimate Medical Academy.

Share article on social media or email:

DeCurtis Corporation Launches Safety Pilot Program at Seattle’s Woodland Park Zoo


News Image

“We are extremely impressed with the Woodland Park Zoo’s health protocols to date and our solution, DeCurtis Shield™ will now create additional value, efficiency and enhance their current processes,” said Camille Olivere, Senior Vice President Sales and Marketing, DeCurtis Corporation.

DeCurtis Corporation, the premier provider of location and proximity enabled solutions in complex, indoor environments with a focus on health, safety and security, operational enhancement and experience evolution announces the launch of DeCurtis Shield™ at Woodland Park Zoo in Seattle, Washington in a pilot effort to enhance the health, safety and security of participating employees and special event visitors.

The nonprofit Woodland Park Zoo offers a safe, 92-acre urban forest retreat to Northwest communities, and now operates under enhanced safety protocols including guest and staff face coverings, social distancing and frequent cleaning.

“As a local destination, not only do we have our guests and staff to keep safe, but also the nearly 1,000 animals that call this place home,” says Michele Smith, Chief Financial Officer at Woodland Park Zoo. “We’re excited to see how this pilot can add layers of protection and peace of mind in a place that has become a true community oasis.”

DeCurtis Shield™ will launch as a pilot for guest services employees and special event group visitors. DeCurtis Shield™ Kiosks will assess temperature using smart thermography cameras at the thermal brain tunnel with patent-pending methodology to provide the fastest and most accurate body temperature. Shield Kiosks can be used at any security entry or exit point in the zoo or event venues on property to seamlessly screen for elevated body temperature.

“We are extremely impressed with the Woodland Park Zoo’s health protocols to date and our solution, DeCurtis Shield™ will now create additional value, efficiency and enhance their current processes,” said Camille Olivere, Senior Vice President Sales and Marketing, DeCurtis Corporation. “Not only will employees and visitors have additional confidence, we see many implications to leverage our technology to achieve the zoo’s objective to further enhance operational efficiency and visitor experience in the future.”

The program launches August 25 and will run for sixty days. If successful, the zoo may expand the effort to a wider scale for employees and select guests.

About DeCurtis Corporation

DeCurtis Corporation is the premier provider of location and proximity enabled solutions in complex indoor environments with a focus on health, safety and security, operational enhancement and experience evolution. Creator of Mobile Assembly Suite (MAS™), the DeCurtis Experience Platform (DXP™), and DeCurtis Shield™, DeCurtis Corporation is the leader in providing transformational experience technology based on decades of deep industry knowledge in the cruise space that is applicable to other sectors. With a vast range of experience working with some of the world’s best, most-recognized brands, DeCurtis Corporation transforms the guest experience to be safer, secure and more efficient through the creative application of the latest technology. For more information on DeCurtis Corporation, please visit http://www.decurtis.com.

About Woodland Park Zoo

Founded in 1899, Woodland Park Zoo engages more than a million visitors of all ages, backgrounds, abilities, and walks of life in extraordinary experiences with animals, inspiring them to make conservation a priority in their lives. The zoo is helping to save animals and their habitats in the wild through more than 35 wildlife conservation projects in the Pacific Northwest and around the world. Woodland Park Zoo is accredited by the Association of Zoos & Aquariums and certified by the rigorous American Humane Conservation program. The Humane Certified™ seal of approval is another important validation of the zoo’s long-standing tradition of meeting the highest standards in animal welfare. Visit http://www.zoo.org and follow the zoo on Facebook, Twitter and Instagram.

Share article on social media or email:



Healthier Generation Celebrates School Leaders Addressing Student Health Needs Relevant During COVID-19 Crisis


“Over time, these awardees established strong foundations in health – allowing them to pivot and adapt to meet acute health and wellness needs in a year unlike any other.” – Kathy Higgins, CEO, Alliance for a Healthier Generation

The Alliance for a Healthier Generation (Healthier Generation), one of the nation’s preeminent children’s health organizations, is honoring 517 schools across the nation – 78% of which serve students from under-resourced communities – for promoting quality nutrition, regular physical activity and strong wellness policies.

Though the submission data for this year’s list – recognized annually as “America’s Healthiest Schools” – was gathered prior to COVID-19-related school closures, schools that leveraged these strong foundations in wellness were positioned to prioritize healthy habits throughout the pandemic; for example:

  • Preparing and distributing free, healthy meals to families
  • Offering virtual, healthy cooking classes
  • Hosting interactive physical education classes online
  • Creating virtual community-based events to raise funds for local food pantries and essential services
  • Establishing rotating schedules to tend to and harvest fresh produce from school gardens
  • Distributing online social-emotional and mental health resources to students, families and staff


For nearly 15 years, Healthier Generation’s annual recognition program has honored schools that are implementing best practices that support children’s learning and development, including meeting or exceeding federal standards for nutritious school meals and providing regular opportunities for students and staff to be active throughout the school day. It remains one of the country’s longest-running, nationwide recognition programs honoring schools for achievements in nutrition, physical activity and wellness policies.

“We commend this cohort of school leaders for prioritizing the essential health needs of students and staff in a time of great challenge and with limited resources at their disposal,” said Kathy Higgins, chief executive officer of the Alliance for a Healthier Generation. “Over time, these awardees established strong foundations in health – allowing them to pivot and adapt to meet acute health and wellness needs in a year unlike any other.”

“School leaders play a critical role in supporting children’s health,” said Donna Mazyck, executive director of the National Association of School Nurses (NASN). “NASN believes that good nutrition, regular physical activity and social-emotional wellness are key building blocks to academic success, and we applaud this cohort of schools for their commitment to helping students thrive.”

Healthier Generation’s work with schools is supported by American Electric Power, The Assisi Foundation of Memphis, BlueCross BlueShield of South Carolina Foundation, the Centers for Disease Control and Prevention, The Fullerton Foundation, Kaiser Permanente, Kohl’s, Mary Black Foundation, Missouri Foundation for Health, Mt. Sinai Health Care Foundation, the Robert Wood Johnson Foundation, Saint Luke’s Foundation, Sanford Harmony and Sleep Number.

To view the complete list of awardees, visit HealthiestSchools.org.

About the Alliance for a Healthier Generation

The Alliance for a Healthier Generation believes every child deserves a healthy future. For over a decade, Healthier Generation has empowered kids to develop lifelong healthy habits by ensuring the environments that surround them provide and promote good health. Driven by our passion that all young people deserve a chance to live healthier lives, our work, in total, has reached more than 29 million kids across the country. To learn more and help make a difference, visit HealthierGeneration.org and join us on Facebook and Twitter.

Share article on social media or email:



Glee Star is fighting to Cure FSH Muscular Dystrophy as National Walk & Roll Ambassador


Max Adler is national ambassador for the Walk & Roll to Cure FSHD

Max Adler is national ambassador for the Walk & Roll to Cure FSHD

“I watched my Mom and Grandma struggle with this disease, and I don’t want that to happen to anyone, anywhere, ever again,” Max Adler said.

The FSHD Society, a 501c3 nonprofit patient advocacy organization, announced today that Max Adler, an actor best known for his roles on the hit series “Glee,” available for streaming on Netflix, and “Switched at Birth”, is serving as this year’s national ambassador for the organization’s signature fundraiser, Walk & Roll to Cure FSHD, taking place September 12. There are currently no treatments available to people with FSHD and with Max Adler’s help the FSHD Society is hoping to raise $500,000 to be put towards research and drug development with the goal of having an approved therapy by 2025.

While Covid-19 forced the FSHD Society to shift their annual Walk & Roll to a virtual format, Adler enthusiastically accepted the challenge of raising awareness and funds despite difficult landscape because of his personal connection to FSHD, one of the most prevalent forms of Muscular Dystrophy. FSHD attacks the muscles in many parts of the body, often affecting people’s ability to smile, lift objects, and walk.

“I watched my Mom and Grandma struggle with this disease, and I don’t want that to happen to anyone, anywhere, ever again,” said Adler. “My grandmother, for example, had a motorized scooter attached to the back of her car, and every time she parked, I remember having to assist her with being able to get out of the driver’s seat, which was no easy task, and helping her walk ever so slowly to the back of the car to get the scooter, holding onto the car so she wouldn’t fall. The hot, hot, burning car in the Arizona sun. It was agonizing to see.”

“My mother was also diagnosed with FSHD, as the disease can be passed genetically,” Adler explains. “Simple things like walking from her bedroom to the living room required a rolling stool for her to lean on because she could no longer walk upright. Other things that usually don’t require much effort or thought such as grabbing a coffee mug from a shelf above your head became the most arduous challenges for her, bringing tears to her eyes, which of course then brought them to mine.”

“The money we’re raising by participating in this Walk & Roll is supporting programs and funding research that will directly impact patients and their families living with FSHD,” Adler said. “Every dollar raised brings us closer to a treatment…I hear it could be as soon as 2025.”

As national ambassador, Adler is inviting his fans to join him in fundraising for FSHD research or by raising awareness through posting to social media with #curefshd #nationalwalkroll. Walk & Roll participants will have an opportunity to win a special “Moment with Max.” Winners in each category below will be invited to a live Facebook event on September 12 to chat, one-on-one, with Adler.


  • Highest Fundraiser – the walker/roller who raises the most money on their personal page (whether participating as an individual or on a team);
  • Captain of the Largest Team – the team captain that recruits the most active team members and has the highest number of their team members raise any amount;
  • Social Butterfly – largest social footprint, tracked by using #NationalFSHDWalkRoll, #CureFSHD, and a local event hashtag.

Supporters across the U.S. (and beyond) can register for the FSHD Society National Virtual Walk & Roll by visiting FSHDSociety.org/walk-Roll. Supporters can also tune in on the FSHD Society Facebook Live telethon on September 12 to watch special appearances with Max Adler, patients and leading researchers.

About Max Adler

Actor Max Adler is best known for his work on the multiple award-winning hit shows “Glee” and “Switched at Birth,” appearing as the closeted slushy throwing football bully Dave Karofsky, and class clown accused of sexual assault Tank, respectively. Adler can now be seen in the hit Sundance Festival film Mope, currently streaming on iTunes and Amazon, as well as Aaron Sorkin’s The Trial of the Chicago 7, being released on Netflix on October 16, 2020, on which he also serves as co-executive producer. Adler is heavily involved with activism and charity organizations such as the It Gets Better Project in which his video has garnered over a half a million views on YouTube, The Trevor Project, GLAAD, and the FSHD Society. Witnessing his late mother and grandmother struggle with FSH Muscular Dystrophy sent Adler on a path to find a treatment and cure so no other family will ever have to battle this disease and struggle with it. Adler currently resides in Los Angeles with his wife, Jennifer, and newborn son, Dylan.

About the FSHD Society (http://www.fshdsociety.org)

The FSHD Society is the world’s largest research-focused patient organization for facioscapulohumeral muscular dystrophy (FSHD), one of the most prevalent forms of muscular dystrophy. The Society has catalyzed major advancements and is accelerating the development of treatments and a cure to end the pain, disability, and suffering endured by one million people worldwide who live with FSHD. The FSHD Society has transformed the landscape for FSHD research and is committed to making sure that no one faces this disease alone. The Society offers a community of support, news, and information through its website at https://www.fshdsociety.org.

Share article on social media or email:

Ellerca Health Changes Chronic Care Landscape Putting People First with the Launch of 360Care


News Image

The future of healthcare is personal, virtual, and fully engaged. With the right tools in one’s pocket users play an active, empowered, and highly effective role in their own care.

Shifting the healthcare paradigm to engage and empower consumers, Ellerca Health is transforming chronic disease management, patient outcomes, and healthcare costs with its 360Care platform.

Ellerca Health, is a digital health organization that uses the integration of mobile technology, real human interaction, artificial intelligence, and proven behavioral science to revolutionize the personal experience and health outcomes of people living with chronic disease. Ellerca Health’s approach delivers continuous fully integrated virtual care and support, raising the bar in the digital therapeutics market. The complete remote care model provided by 360Care is perfectly suited to the evolving needs of patients and providers in the midst of the global COVID-19 pandemic. Driving 360Care is the core philosophy that people with chronic health needs, when provided with true care and companionship, quickly make the incremental behavioral changes needed to stop the progression of their conditions. Ellerca Health’s 360Care makes behavior change easy.

Pioneering a new service space in Canadian healthcare, 360Care is a personalized digital health coaching app for the management of Type 2 diabetes and other chronic diseases. With empathetic medical experts building motivation in patients and cutting-edge technology delivering round-the-clock health monitoring, Ellerca Health is focused on delivering better clinical outcomes. With 360Care’s pioneering mobile technology, healthcare consumers have access to live expert care, AI-driven health plans, secure health data recording, targeted disease management education, and the motivational framework to make positive change happen. The 360Care app individualizes diabetes monitoring, including regular blood glucose testing, BMI-focused meal plans, and varying exercise routines customized to the patient’s fitness level. Access to a first-rate team of health professionals, including certified diabetes educators, dieticians, and key specialists, allows patients to receive the support and expertise they need to relieve symptoms, achieve their health goals, and live better lives.

“The future of healthcare is personal, virtual, and fully engaged. With the right tools in one’s pocket users play an active, empowered, and highly effective role in their own care,” says Daniel Yeboah, Founder and General Manager of Ellerca Health.

Currently, one in three Canadians has diabetes or prediabetes. Type 2 diabetes accounts for 90 to 95 percent of cases. According to the PWC Health Research Institute report, most American consumers desire new digital therapies and connected devices as treatment options, moreover, physicians are inclined towards the use of these tools as well. Additionally, the Government of Canada aims for transformative growth in the health and bioscience industry by advocating nationally robust, digitalized, interconnected and patient-centered health data infrastructure.

With 360Care, Ellerca Health is bringing to market a vital solution to bring about change in the lives of millions of people in Canada and worldwide. Improving the health of individuals with diabetes and prediabetes by lowering HbA1c, reducing weight, and dropping ASCVD risk scores, lowers the overall costs of care carried by consumers, employers, insurers, and the government. The benefits of Ellerca Health’s digital health management platform are appreciated by patients, caregivers, providers, and payers alike.

Addressing increasing concerns about privacy in a connected world, Ellerca Health’s digital platform quickly provides critical patient data to providers in a secure environment ensuring that every user’s medical care team has the right contextual information to give attentive, insightful, private, and compassionate care. For healthcare consumers, having care providers actually know what is going on with one’s health is a gamechanger, creating a sense of companionship and alleviating the burden of navigating challenging healthcare journeys alone.

360Care helps people with chronic disease engage with digital therapy and improve outcomes by:

  • Providing medication reminders, motivational support, guidance, and treatment techniques
  • Connecting users with expert care via live chat, audio, and video – from home or on the go
  • Using cognitive and motivational stimulation to promote habit changes key to delaying or preventing the onset or progression of chronic disease
  • Presenting proven health education modules personalized to each user’s needs
  • Connecting to wearables and consumer health electronics to track key health indicators

About Ellerca Health:

Based in Toronto, Canada, Ellerca Health delivers integrated digital therapy harnessing the ease and privacy of mobile technology, the predictive power of AI, and the wisdom and compassion of real human interaction.

Share article on social media or email: